A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/00 (2006.01) A61K 31/395 (2006.01) A61K 31/435 (2006.01) A61K 31/438 (2006.01) A61K 31/445 (2006.01) A61K 31/451 (2006.01) A61K 31/535 (2006.01) A61K 31/5375 (2006.01) A61K 31/5377 (2006.01) C07D 211/56 (2006.01) C07D 491/10 (2006.01)
Patent
CA 2273853
The present invention provides the use of an orally active, long acting, CNS- penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of cognitive disorders, methods of medical treatment using such an NK-1 receptor antagonist and pharmaceutical compositions comprising it.
L'invention porte sur l'utilisation d'un antagoniste-retard du récepteur NK-1 oralement actif, capable de pénétrer le SNC et destiné à la fabrication d'un médicament administrable par voie orale en traitement ou en prévention de troubles cognitifs. L'invention porte aussi sur des traitements médicaux utilisant l'antagoniste du récepteur NK-1 et des compositions pharmaceutiques le contenant.
Baker Raymond
Curtis Neil Roy
Elliott Jason Matthew
Harrison Timothy
Hollingworth Gregory John
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of nk-1 receptor antagonists for treating cognitive... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of nk-1 receptor antagonists for treating cognitive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nk-1 receptor antagonists for treating cognitive... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1632818